City of Kivalina Awards Settlement Agreement Contract to ALLERGAN (April 2023)
City of KivalinaCity · AK- Approved
- Apr 5, 2023
The 30-second brief
City of Aliso Viejo opts into settlement agreement with two opioid manufacturers-Allergan and Teva and direct the City Manager or his designee to execute any documents necessary to implement the action and, when possible, allocate the City's designated share of settlement funds to the County of Orange.
ALLERGAN holds this settlement agreement contract with City of Kivalina. Its other public contracts on record include work for City of Richmond and City of Gresham.
See every contract and contact at City of Kivalina.
See every contractFree account · 30-second setup · No credit card
Contract details
- Contract type
- Settlement Agreement
- Document date
- April 5, 2023
- Term
- NA
- Vendor
- ALLERGAN
- Agency
- City of Kivalina
- Source document
- aliso-viejo-city-council-minutes-opioid-settlement-funds-accounts-payable-apr-5-2023_aa7.pdf (Minutes)
ALLERGAN's other public contracts
More City of Kivalina contracts
Questions about this contract
Who was awarded the settlement agreement contract by City of Kivalina?
ALLERGAN was awarded this settlement agreement contract by City of Kivalina, as recorded on April 5, 2023.
What type of contract is this?
This is a Settlement Agreement contract, documented as a minutes record.
Where was this contract approved?
This contract appears in aliso-viejo-city-council-minutes-opioid-settlement-funds-accounts-payable-apr-5-2023_aa7.pdf (Minutes), dated April 5, 2023 from City of Kivalina. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
What other contracts does ALLERGAN hold?
ALLERGAN may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.
Show 1 more question
What is City of Kivalina currently buying?
Explore City of Kivalina's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.